Chemotherapy and Radiation in Treating Patients With Stage 3 Non-Small Cell Lung Cancer (PROCLAIM)

Study Status

Open to Enrollment

Study Description

This study will compare the overall survival of patients with locally advanced, Stage III Non-Small Cell Lung Cancer with nonsquamous cell histology. 

This study has two arms:

  • Arm A (Experimental Interventions): Pemetrexed, Cisplatin, Thoracic Radiation Therapy
  • Arm B (Active Comparator Intervention): Etoposide, Cisplatin, Vinorelbine. Paclitaxel, Carboplatin. Thoracic Radiation Therapy

Disease Status and/or Stage

Unresectable, Locally Advance, Stage III Non-Small Cell Lung Cancer


Eli Lily & Co.

Key Eligibility

  • Men and women, age 18 and older
  • Stage 3A or 3B Non-Small Cell Lung Cancer of the non-squamous type
  • Measurable tumor lesions
  • Additional eligibility discussed when you contact the study team

Principal Investigator

Ronald Scheff, MD


  • Gina Mileo
  • 212-746-5430

Healthy Volunteers


As a healthy volunteer in a clinical trial you may make a significant contribution to the discovery of medical knowledge and new treatments that could impact people around the world.
Click here for studies seeking healthy volunteers.

Contact Us

For general inquiries, or if you need assistance finding a study, please contact:

Erica Bersin
Tel: (646) 962-8232
[email protected]

Top of page